A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Psoriasis
Related studies linked through entity extraction aliases.
Haut-Tief Patient Education on Psoriasis and Eczema
- Status
- UNKNOWN
- Phase
- NA
Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
- Status
- COMPLETED
- Phase
- PHASE3
Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
- Status
- COMPLETED
- Phase
- PHASE3
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis
- Status
- COMPLETED
- Phase
- NA
Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
- Status
- COMPLETED
- Phase
- PHASE4
A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Reduction of Pain Caused by Biologic Drugs in Psoriasis
- Status
- COMPLETED
- Phase
- NA
Excimer Laser, Serum Markers & Psoriasis
- Status
- WITHDRAWN
- Phase
- NA
Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects
- Status
- COMPLETED
- Phase
- PHASE1
An Exploratory Genetic Study in Participants With Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
- Status
- COMPLETED
- Phase
- N/A
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4